American Journal of Clinical Oncology
-
Publication Venue For
-
Ra-223 Treatment for Bone Metastases in Castrate-Resistant Prostate Cancer: Practical Management Issues for Patient Selection..
42:399-406.
2019
-
Survival Benefit of Adjuvant Radiation Therapy in Node-positive Vulvar Cancer..
41:845-850.
2018
-
Chemoradiation Versus Chemotherapy in Uterine Carcinosarcoma: Patterns of Care and Impact on Overall Survival..
41:784-791.
2018
-
Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases: An International Survey of >1000 Radiation Oncologists..
40:418-422.
2017
-
The Benefit of Chemotherapy in Esophageal Cancer Patients With Residual Disease After Trimodality Therapy..
39:136-141.
2016
-
The Effect of Receiving Treatment Within a Clinical Trial Setting on Survival and Quality of Care Perception in Advanced Stage Non-Small Cell Lung Cancer..
39:126-131.
2016
-
Management of Postprostatectomy Biochemical Relapse With Salvage Radiotherapy: Results of an International Survey..
39:64-68.
2016
-
Pain Intensity and Pain Interference in Patients With Lung Cancer: A Pilot Study of Biopsychosocial Predictors..
38:457-464.
2015
-
Adjuvant versus salvage radiation therapy for prostate cancer patients with adverse pathologic features: comparative analysis of long-term outcomes..
38:55-60.
2015
-
Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy..
37:433-437.
2014
-
Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy.
37:433-437.
2014
-
Factors associated with use of preoperative chemoradiation therapy for rectal cancer in the Cancer Care Outcomes Research and Surveillance Consortium..
36:572-579.
2013
-
Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma..
36:589-595.
2013
-
Adherence to adjuvant hormonal therapy and its relationship to breast cancer recurrence and survival among low-income women..
36:181-187.
2013
-
Complication rates in patients with negative axillary nodes 10 years after local breast radiotherapy after either sentinel lymph node dissection or axillary clearance..
36:12-19.
2013
-
Concurrent chemotherapy and intensity-modulated radiotherapy for organ preservation of locoregionally advanced oral cavity cancer..
34:356-361.
2011
-
Cetuximab, paclitaxel, carboplatin, and radiation for head and neck cancer: a toxicity analysis..
33:144-147.
2010
-
S9511: a Southwest Oncology Group phase II study of trimetrexate, 5-fluorouracil, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach..
33:117-120.
2010
-
Surveillance, Epidemiology, and End Results (SEER) database analysis of microcystic adnexal carcinoma (sclerosing sweat duct carcinoma) of the skin..
33:125-127.
2010
-
A Phase II trial of Denileukin Diftitox in patients with previously treated advanced non-small cell lung cancer..
32:269-273.
2009
-
Paraganglioma of the head and neck: long-term local control with radiotherapy..
32:304-307.
2009
-
Image-guided percutaneous thermal ablation for the palliative treatment of chest wall masses..
30:361-367.
2007
-
Chemotherapy and high dose radiotherapy followed by resection for locally advanced nonsmall cell lung cancers..
30:258-263.
2007
-
Docetaxel plus gemcitabine in recurrent and/or metastatic squamous cell carcinoma of the head and neck: a phase II multicenter study..
30:278-282.
2007
-
A simple model predicts freedom from biochemical recurrence after low-dose rate prostate brachytherapy alone..
30:199-204.
2007
-
Confidence intervals and survival estimates: a systematic review of 3 oncology journals..
29:405-407.
2006
-
Phase II trial of gemcitabine plus irinotecan in patients with esophageal cancer: a Southwest Oncology Group (SWOG) trial..
29:116-122.
2006
-
Cyclooxygenase-2 (COX-2) levels before and after chemotherapy: a study in rectal cancer..
28:560-564.
2005
-
Cyclooxygenase-2 (COX-2) levels before and after chemotherapy: a study in rectal cancer..
28:560-564.
2005
-
Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: implications for stereotactic body radiotherapy..
28:576-580.
2005
-
A low rate of central nervous system progression in a phase II trial of outpatient chemobiologic therapy with cisplatin, temozolomide, interleukin-2, and interferon alfa 2-B for metastatic malignant melanoma..
28:479-484.
2005
-
An unusual cause of cholecystitis?.
28:529-530.
2005
-
Evaluation of the effect of age on treatment-related mortality and relapse in patients with high-risk primary breast cancer receiving high-dose chemotherapy..
28:248-254.
2005
-
Radiation dose considerations in the palliative treatment of locally advanced adenocarcinoma of the pancreas..
28:227-233.
2005
-
A phase II study of single agent gemcitabine in relapsed or refractory follicular or small lymphocytic non-Hodgkin lymphomas: a Hoosier Oncology Group Study..
28:169-172.
2005
-
A phase III trial evaluating the combination of cisplatin, etoposide, and radiation therapy with or without tamoxifen in patients with limited-stage small cell lung cancer: Cancer and Leukemia Group B Study (9235)..
28:81-90.
2005
-
Economic evaluation of zoledronic acid versus pamidronate for the prevention of skeletal-related events in metastatic breast cancer and multiple myeloma..
28:8-16.
2005
-
Phase II trial of vinorelbine plus doxorubicin in relapsed small-cell lung cancer: CALGB 9332..
27:19-23.
2004
-
Cyclooxygenase-2 (COX-2) expression in human meningioma as a function of tumor grade..
26:S98-102.
2003
-
Selection of patients with melanoma brain metastases for aggressive treatment..
26:354-357.
2003
-
Neoadjuvant doxil chemotherapy prior to androgen ablation plus radiotherapy for high-risk localized prostate cancer: feasibility and toxicity..
26:312-316.
2003